Position in PFE
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$6,451,248
+$4,352,830 QoQ
Shares Held
267,909
+258.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#530
of 2,821 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cornerstone Capital, Inc. holds $113,799,273 across 8 Drug Manufacturers - General names. PFE ranks #4 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
154,756 | $38,942,799 | |
| 2 | AMGN |
Amgen Inc
|
90,924 | $32,925,398 | |
| 3 | JNJ |
Johnson & Johnson
|
115,036 | $29,215,692 | |
| 4 | PFE |
Pfizer Inc
This page
|
267,909 | $6,451,248 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
36,158 | $4,568,201 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,642 | $596,497 | |
| 7 | LLY |
ELI LILLY & Co
|
485 | $581,723 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
8,985 | $517,715 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,451,248 | 267,909 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,098,418 | 74,730 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $605,443 | 24,315 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $619,546 | 24,315 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $418,915 | 17,282 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $445,857 | 17,595 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $466,795 | 17,595 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $534,984 | 18,486 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $492,308 | 17,595 | Shares | Sole | 2024-08-02 | |
| 2023-09-30 | $490,916 | 14,800 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $542,864 | 14,800 | Shares | Sole | 2023-08-21 | |
| 2023-03-31 | $603,840 | 14,800 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $758,352 | 14,800 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $725,540 | 16,580 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $794,314 | 15,150 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $807,094 | 15,590 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $448,780 | 7,600 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $283,866 | 6,600 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $258,456 | 6,600 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $239,118 | 6,600 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $242,946 | 6,600 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $242,219 | 6,600 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $209,280 | 6,400 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $208,895 | 6,400 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||